Inari Medical, Inc. Operating Expenses
Inari Medical, Inc. reported Operating Expenses of $147.11 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-10-28
- Inari Medical, Inc. operating expenses for the quarter ending 2024-09-30 was $147.11M, a 34.01% increase year-over-year.
- Inari Medical, Inc. operating expenses for the quarter ending 2024-06-30 was $148.27M, a 39.00% increase year-over-year.
- Inari Medical, Inc. operating expenses for the quarter ending 2024-03-31 was $141.48M, a 31.29% increase year-over-year.
- Inari Medical, Inc. operating expenses for the quarter ending 2023-12-31 was $124.39M, a 23.72% increase year-over-year.
- Inari Medical, Inc. operating expenses for fiscal 2023 was $448.60M, a 22.21% increase from fiscal 2022.
- Inari Medical, Inc. operating expenses for fiscal 2022 was $367.06M, a 52.07% increase from fiscal 2021.
- Inari Medical, Inc. operating expenses for fiscal 2021 was $241.38M, a 123.20% increase from fiscal 2020.
- Inari Medical, Inc. operating expenses for fiscal 2020 was $108.14M, a 143.48% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2024-09-30 | $147.11M 10-Q · filed 2024-10-28 | $295.38M derived: sum of 2 quarters · filed 2024-10-28 | $436.86M 10-Q · filed 2024-10-28 | $561.25M derived: sum of 4 quarters · filed 2024-10-28 |
| 2024-06-30 | $148.27M 10-Q · filed 2024-07-30 | $289.75M 10-Q · filed 2024-07-30 | $414.13M derived: sum of 3 quarters · filed 2024-07-30 | $523.91M derived: sum of 4 quarters · filed 2024-10-28 |
| 2024-03-31 | $141.48M 10-Q · filed 2024-04-30 | $265.86M derived: sum of 2 quarters · filed 2024-04-30 | $375.64M derived: sum of 3 quarters · filed 2024-10-28 | $482.31M derived: sum of 4 quarters · filed 2024-10-28 |
| 2023-12-31 | $124.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $234.16M derived: sum of 2 quarters · filed 2024-10-28 | $340.83M derived: sum of 3 quarters · filed 2024-10-28 | $448.60M 10-K · filed 2024-02-29 |
| 2023-09-30 | $109.78M 10-Q · filed 2024-10-28 | $216.45M derived: sum of 2 quarters · filed 2024-10-28 | $324.21M 10-Q · filed 2024-10-28 | $424.75M derived: sum of 4 quarters · filed 2024-10-28 |
| 2023-06-30 | $106.67M 10-Q · filed 2024-07-30 | $214.44M 10-Q · filed 2024-07-30 | $314.97M derived: sum of 3 quarters · filed 2024-07-30 | $409.91M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $107.76M 10-Q · filed 2024-04-30 | $208.30M derived: sum of 2 quarters · filed 2024-04-30 | $303.24M derived: sum of 3 quarters · filed 2024-04-30 | $394.96M derived: sum of 4 quarters · filed 2024-04-30 |
| 2022-12-31 | $100.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $195.47M derived: sum of 2 quarters · filed 2024-02-29 | $287.20M derived: sum of 3 quarters · filed 2024-02-29 | $367.06M 10-K · filed 2024-02-29 |
| 2022-09-30 | $94.94M 10-Q · filed 2023-11-01 | $186.66M derived: sum of 2 quarters · filed 2023-11-01 | $266.53M 10-Q · filed 2023-11-01 | $339.72M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $91.72M 10-Q · filed 2023-08-02 | $171.59M 10-Q · filed 2023-08-02 | $244.78M derived: sum of 3 quarters · filed 2024-02-29 | $313.39M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $79.87M 10-Q · filed 2023-05-03 | $153.06M derived: sum of 2 quarters · filed 2024-02-29 | $221.66M derived: sum of 3 quarters · filed 2024-02-29 | $276.19M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $73.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $141.79M derived: sum of 2 quarters · filed 2024-02-29 | $196.32M derived: sum of 3 quarters · filed 2024-02-29 | $241.38M 10-K · filed 2024-02-29 |
| 2021-09-30 | $68.60M 10-Q · filed 2022-11-02 | $123.13M derived: sum of 2 quarters · filed 2022-11-02 | $168.19M 10-Q · filed 2022-11-02 | $206.12M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $54.53M 10-Q · filed 2022-08-03 | $99.59M 10-Q · filed 2022-08-03 | $137.52M derived: sum of 3 quarters · filed 2023-02-27 | $165.81M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $45.06M 10-Q · filed 2022-05-04 | $82.99M derived: sum of 2 quarters · filed 2023-02-27 | $111.29M derived: sum of 3 quarters · filed 2023-02-27 | $133.79M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $37.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $66.23M derived: sum of 2 quarters · filed 2023-02-27 | $88.73M derived: sum of 3 quarters · filed 2023-02-27 | $108.14M 10-K · filed 2023-02-27 |
| 2020-09-30 | $28.30M 10-Q · filed 2021-11-09 | $50.80M derived: sum of 2 quarters · filed 2021-11-09 | $70.22M 10-Q · filed 2021-11-09 | $86.79M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $22.51M 10-Q · filed 2021-08-10 | $41.92M 10-Q · filed 2021-08-10 | $58.50M derived: sum of 3 quarters · filed 2022-02-23 | $70.32M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $19.41M 10-Q · filed 2021-05-11 | $35.99M derived: sum of 2 quarters · filed 2022-02-23 | $47.81M derived: sum of 3 quarters · filed 2022-02-23 | $57.19M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $16.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $28.40M derived: sum of 2 quarters · filed 2022-02-23 | $37.78M derived: sum of 3 quarters · filed 2022-02-23 | $44.42M 10-K · filed 2022-02-23 |
| 2019-09-30 | $11.82M 10-Q · filed 2020-11-12 | $21.20M derived: sum of 2 quarters · filed 2020-11-12 | $27.84M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $9.38M 10-Q · filed 2020-08-11 | $16.02M 10-Q · filed 2020-08-11 | ||
| 2018-12-31 | $14.69M 10-K · filed 2021-03-09 |